-
1دورية أكاديمية
المؤلفون: Subhanwita Sarkar, Ayan Chanda, Rutvij A. Khanolkar, Meghan Lambie, Laurie Ailles, Scott V. Bratman, Aru Narendran, Pinaki Bose
المصدر: Biomedicines, Vol 12, Iss 3, p 503 (2024)
مصطلحات موضوعية: OSCC, polo-like-kinase-1, γ-radiation therapy, volasertib, Biology (General), QH301-705.5
وصف الملف: electronic resource
-
2دورية أكاديمية
المؤلفون: Uwe Platzbecker, Joerg Chromik, Jan Krönke, Hiroshi Handa, Stephen Strickland, Yasushi Miyazaki, Martin Wermke, Wataru Sakamoto, Yoshifumi Tachibana, Tillmann Taube, Ulrich Germing
المصدر: BMC Cancer, Vol 22, Iss 1, Pp 1-9 (2022)
مصطلحات موضوعية: Volasertib, Phase I, Myelodysplastic syndrome, Chronic myelomonocytic leukemia, Acute myeloid leukemia, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: https://doaj.org/toc/1471-2407Test
-
3دورية أكاديمية
المصدر: Cancers; Volume 15; Issue 9; Pages: 2589
مصطلحات موضوعية: non-small cell lung cancer, PLK1, EGFR, c-Cbl, Osimertinib, Volasertib
وصف الملف: application/pdf
العلاقة: Cancer Therapy; https://dx.doi.org/10.3390/cancers15092589Test
-
4دورية أكاديمية
المؤلفون: Thibault Passeri, Ahmed Dahmani, Julien Masliah-Planchon, Rania El Botty, Laura Courtois, Sophie Vacher, Elisabetta Marangoni, Fariba Nemati, Sergio Roman-Roman, Homa Adle-Biassette, Hamid Mammar, Sébastien Froelich, Ivan Bièche, Didier Decaudin
المصدر: Frontiers in Oncology, Vol 12 (2022)
مصطلحات موضوعية: CDKN2A/2B deletion, chordoma patient’s derived xenograft, CDK4/6 inhibitor, palbocicib, PLK1 inhibitor, volasertib, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: https://www.frontiersin.org/articles/10.3389/fonc.2022.960720/fullTest; https://doaj.org/toc/2234-943XTest
-
5دورية أكاديمية
المؤلفون: Yousef, Eman H, El-Mesery, Mohamed E, Habeeb, Maha R, Eissa, Laila A
المصدر: Naunyn Schmiedebergs Arch Pharmacol ; ISSN:1432-1912 ; Volume:397 ; Issue:7
مصطلحات موضوعية: Diosgenin, Doxorubicin, Hepatocellular carcinoma, Polo-like kinase 1, Proliferating cell nuclear antigen, Volasertib
العلاقة: https://doi.org/10.1007/s00210-023-02894-8Test; https://pubmed.ncbi.nlm.nih.gov/38165424Test
-
6دورية أكاديمية
المؤلفون: Lifeng Li, Wenhua Xue, Zhibo Shen, Jie Liu, Min Hu, Zhenyong Cheng, Yuxing Wang, Yulu Chen, Hao Chang, Yingyi Liu, Bin Liu, Jie Zhao
المصدر: Molecular Therapy: Oncolytics, Vol 18, Iss , Pp 215-225 (2020)
مصطلحات موضوعية: immunomodulatory drugs, IMiDs, CC-885, PLK1, volasertib, NSCLC, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: http://www.sciencedirect.com/science/article/pii/S2372770520300929Test; https://doaj.org/toc/2372-7705Test
-
7دورية أكاديمية
المؤلفون: Fernández Sainz, Jesús, Pacheco Liñán, Pedro José, Granadino Roldán, José M., Bravo Pérez, Iván, Rubio Martínez, Jaime, Albaladejo, José, Garzón-Ruiz, Andrés
مصطلحات موضوعية: PLK1, BI-2536, Volasertib, BI-6727, Ro-3280, Fluorescence spectroscopy, Molecular modeling
وصف الملف: application/pdf
العلاقة: 2020-GRIN-29016; FQM-337; 2018/15132; Fernández-Sainz, J., Pacheco-Liñán, P. J., Granadino-Roldán, J. M., Bravo, I., Rubio-Martínez, J., Albaladejo, J. y Garzón-Ruiz, A. (2022). Shedding light on the binding mechanism of kinase inhibitors BI-2536, Volasetib and Ro-3280 with their pharmacological target PLK1. Journal of Photochemistry and Photobiology B: Biology, 232, 112477.; https://hdl.handle.net/10578/36281Test
-
8دورية أكاديمية
المؤلفون: Gyawali, Bishal, Prasad, Vinay
مصطلحات موضوعية: angiogenesis inhibitor, clinical trials, nintedanib, ovarian cancer, statistical significance, volasertib, Rare Diseases, Cancer, Clinical Trials and Supportive Activities, Clinical Research, Ovarian Cancer
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/4dt006b2Test
-
9دورية أكاديمية
المؤلفون: Jolien Van denBossche, Christophe Deben, Ines De Pauw, Hilde Lambrechts, Christophe Hermans, Vanessa Deschoolmeester, Julie Jacobs, Pol Specenier, Patrick Pauwels, Jan Baptist Vermorken, Marc Peeters, Filip Lardon, An Wouters
المصدر: Molecular Oncology, Vol 13, Iss 5, Pp 1196-1213 (2019)
مصطلحات موضوعية: hypoxia, non‐small‐cell lung cancer, p53, Polo‐like kinase 1, senescence, volasertib, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
10دورية أكاديمية
المؤلفون: Dohner, Hartmut, Symeonidis, Argiris, Deeren, Dries, Demeter, Judit, Sanz, Miguel A., Anagnostopoulos, Achilles, Esteve, Jordi, Fiedler, Walter, Porkka, Kimmo, Kim, Hee-Je, Lee, Je-Hwan, Usuki, Kensuke, D'Ardia, Stefano, Won Jung, Chul, Salamero, Olga, Horst, Heinz-August, Recher, Christian, Rousselot, Philippe, Sandhu, Irwindeep, Theunissen, Koen, Thol, Felicitas, Dohner, Konstanze, Teleanu, Veronica, DeAngelo, Daniel J., Naoe, Tomoki, Sekeres, Mikkael A., Belsack, Valerie, Ge, Miaomiao, Taube, Tillmann, Ottmann, Oliver G.
المساهمون: HUS Comprehensive Cancer Center, Department of Medicine, Hematologian yksikkö, Helsinki University Hospital Area
مصطلحات موضوعية: KINASE INHIBITOR VOLASERTIB, LOW-DOSE CYTARABINE, BI 6727, OPEN-LABEL, RECOMMENDATIONS, AZACITIDINE, DECITABINE, MANAGEMENT, VENETOCLAX, DIAGNOSIS, 3122 Cancers
وصف الملف: application/pdf
العلاقة: This study was funded by Boehringer Ingelheim.; Dohner , H , Symeonidis , A , Deeren , D , Demeter , J , Sanz , M A , Anagnostopoulos , A , Esteve , J , Fiedler , W , Porkka , K , Kim , H-J , Lee , J-H , Usuki , K , D'Ardia , S , Won Jung , C , Salamero , O , Horst , H-A , Recher , C , Rousselot , P , Sandhu , I , Theunissen , K , Thol , F , Dohner , K , Teleanu , V , DeAngelo , D J , Naoe , T , Sekeres , M A , Belsack , V , Ge , M , Taube , T & Ottmann , O G 2021 , ' Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy : A Randomized, Phase 3 Trial ' , Hemasphere , vol. 5 , no. 8 , 617 . https://doi.org/10.1097/HS9.0000000000000617Test; ORCID: /0000-0003-4112-5902/work/100697243; fc40d6b8-3854-42a4-9c17-c4ee048f0475; http://hdl.handle.net/10138/334645Test; 000682773000010
النص الكامل